Dr. Richard Caringal Baynosa, MD

Dr. Baynosa practices at Specialty Surgery Center - Las Vegas in Las Vegas, Nevada.

Dr. Baynosa's NPI, 1881718021, was assigned on March 16, 2007. Dr. Baynosa graduated from UC San Diego School of Medicine in 2001. Dr. Baynosa holds Nevada license 13133.

Dr. Baynosa's primary practice is Specialty Surgery Center - Las Vegas, at 7250 Cathedral Rock, Las Vegas, NV 89128. The practice phone is (702) 933-3999.

Dr. Baynosa's primary practice is Specialty Surgery Center - Las Vegas in Las Vegas, Nevada. Dr. Baynosa is also affiliated with University Medical Center. The medical group on file is UNLV Health. Dmand AI also links Dr. Baynosa to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baynosa practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Baynosa's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Baynosa is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Baynosa is licensed in Nevada.

Dmand AI lists breast reconstruction, breast surgery and head wound among the conditions Dr. Baynosa treats.

CMS data shows 26 Medicare services from Dr. Baynosa across 2 procedure codes in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $1,971 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Dr. Baynosa in 2024. The largest group is 65 to 74, with 26 patients. 69% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Baynosa's median patient age at 61, with 94% women.

In 2024, Dr. Baynosa wrote 46 Medicare Part D claims for 17 patients. 91% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $515 in total drug cost. In 2019, CMS named 15 claims across 1 drug.

Dr. Baynosa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of mastectomy by Dr. Baynosa, more than 68% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Baynosa, published from 2009 to 2025. 2014 was the busiest year, with 4. The most frequent topics are Hyperbaric Oxygenation, Reperfusion Injury and Apoptosis. Dr. Baynosa has published most often in Plast Reconstr Surg. Dr. Baynosa's most frequent co-authors are Wei Wang, MD, Ashish Francis and John Patrick Brosious, MD.

Dmand AI links Dr. Baynosa to 1 clinical trial. Conditions studied include Neovascularization, Pathologic and Metaplasia.

CMS Open Payments shows 424 general payments to Dr. Baynosa from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 44% of the total. Allergan Inc. paid the most, $76,689.

Dmand AI lists 1 award for Dr. Baynosa.

Dr. Baynosa graduated from UC San Diego School of Medicine in 2001. Dr. Baynosa is a member of ACS and ASPS.

Dr. Baynosa is in network with 12 carriers, including Aetna, United Healthcare and Humana. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.